Reporting Owner Activity for Nancy Lurker

Form 3/4/5 issuer positions and transaction evidence for this reporting owner.

Linked issuers

Largest position

EyePoint, Inc.

Disclosed value

$9.76M

Transaction activity

Available

Forms 3/4/5 position snapshot: Estimated Forms 3/4/5 value
$9.76M
Estimated from Forms 3/4/5 when filings include enough holding data.
Issuers linked to this owner
4
Distinct issuers connected to this reporting owner in parsed SEC filings.
Largest linked issuer position
EyePoint, Inc. (EYPT)
$7.7M estimated from parsed reporting-owner filings.
Latest parsed owner filing
22 May 2026
Most recent owner-level filing date in the parsed SEC record.
EyePoint, Inc. (EYPT)
Estimated value: $7.7M · 12-month value change: -$150.9K · Role: Director
Alkermes plc. (ALKS)
Estimated value: $1.18M · Role: Director
COLLEGIUM PHARMACEUTICAL, INC (COLL)
Estimated value: $884.9K · 12-month value change: -$161.9K · Role: Director
+1 more
Additional issuer positions are listed below.
How to read Forms 3/4/5 positions
Reported values are estimates from parsed SEC Forms 3/4/5 when the filing includes enough price and share data.
Use this as a filing-backed owner snapshot, not as a live cap table.
Location: Dublin 4
Latest reporting-owner signature: /s/ Shantale Greenson, attorney-in-fact for Nancy Lurker
SEC filing history: Open SEC filing history

Follow Filing Activity

Follow Nancy Lurker and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here